288 related articles for article (PubMed ID: 35860263)
1. Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma.
Qi L; Zhang W; Ren X; Xu R; Yang Z; Chen R; Tu C; Li Z
Front Immunol; 2022; 13():921223. PubMed ID: 35860263
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
3. Correlations between the modification patterns mediated by pyroptosis-related genes, tumor microenvironment, and immunotherapy in soft tissue sarcoma.
Cai Y; Meng J; Qiu Y; Huang X; Du H; Yao J
Medicine (Baltimore); 2024 May; 103(20):e38173. PubMed ID: 38758862
[TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
5. Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma.
Qi L; Chen F; Wang L; Yang Z; Zhang W; Li ZH
Front Pharmacol; 2023; 14():1136184. PubMed ID: 36937870
[No Abstract] [Full Text] [Related]
6. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
7. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study.
Xiao KW; Yang ZQ; Yan X; Liu ZB; Yang M; Guo LY; Cai L
Front Bioeng Biotechnol; 2022; 10():846812. PubMed ID: 35519620
[No Abstract] [Full Text] [Related]
8. Identification of m
Wang X; Mao Y; Xu H; Chen J; Chen X
Heliyon; 2023 Sep; 9(9):e19680. PubMed ID: 37809908
[TBL] [Abstract][Full Text] [Related]
9. m
Yuan B; Qin H; Zhang J; Zhang M; Yang Y; Teng X; Yu H; Huang W; Wang Y
Front Oncol; 2022; 12():1087753. PubMed ID: 36591468
[TBL] [Abstract][Full Text] [Related]
10. RNA m
Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
Front Immunol; 2022; 13():905057. PubMed ID: 36389669
[TBL] [Abstract][Full Text] [Related]
11. The hub ten gene-based risk score system using RNA m
Yuan B; Liu W; Huo M; Zhang J; Yang Y; Gao T; Yin X; Yang T; Teng X; Huang W; Yu H
Breast Cancer; 2022 Jul; 29(4):645-658. PubMed ID: 35174450
[TBL] [Abstract][Full Text] [Related]
12. m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer.
Sheng G; Wang T; Gao Y; Wu H; Wu J
Sci Rep; 2023 Nov; 13(1):19670. PubMed ID: 37952076
[TBL] [Abstract][Full Text] [Related]
13. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
[TBL] [Abstract][Full Text] [Related]
14. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning.
Qi L; Chen F; Wang L; Yang Z; Zhang W; Li Z
Front Pharmacol; 2023; 14():1217488. PubMed ID: 37408763
[No Abstract] [Full Text] [Related]
16. Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.
Zhang R; Gan W; Zong J; Hou Y; Zhou M; Yan Z; Li T; Lv S; Zeng Z; Wang W; Zhang F; Yang M
Front Immunol; 2023; 14():1054700. PubMed ID: 36911744
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer.
Li Z; Zhang X; Weng W; Zhang G; Ren Q; Tian Y
Aging (Albany NY); 2023 Jun; 15(12):5445-5481. PubMed ID: 37319315
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
Hu C; Chen B; Huang Z; Liu C; Ye L; Wang C; Tong Y; Yang J; Zhao C
J Transl Med; 2020 Sep; 18(1):337. PubMed ID: 32873319
[TBL] [Abstract][Full Text] [Related]
19. Correlative Study on the Relationship between the Expression of m6a-Related Genes and the Prognosis and Immunotherapy of Soft Tissue Sarcoma.
Qiu Y; Li J; Yao J; Meng J; Huang X; Zheng X; Wen Z; Huang J; Wang H
Biomed Res Int; 2022; 2022():5439023. PubMed ID: 38024481
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis reveals the competing endogenous RNA (ceRNA) coexpression network in the tumor microenvironment and prognostic biomarkers in soft tissue sarcomas.
Zou D; Wang Y; Wang M; Zhao B; Hu F; Li Y; Zhang B
Bioengineered; 2021 Dec; 12(1):496-506. PubMed ID: 33587010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]